GSK’s dealmaking will be “cautious and disciplined” under the current trade war, but the pharma will focus on looking for ...

The South Dakota parents of seven children were "grateful," but admittedly "busy," during a special reunion with NICU staff ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

Flu virus that can lead to paralysis and brain swelling detected in California’s wastewater - This comes on the heels of one ...

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

"The mpox virus is primarily spread by prolonged close contact, typically skin-to-skin, often during sexual activity.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The decision will fall to the CDC’s chief of staff, Matthew Buzzelli, said Department of Health and Human Services ... get vaccinated against respiratory syncytial virus have risks including ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...